
ABLBL
NSEPrice History
Investment Checklist
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Trend
Price below most MAs — downtrend | Bearish MA stack (20<50<200)
Price Action
Support & Resistance Levels
Volume Analysis
Recent MA Crossovers
Stop Loss Levels
Fixed Risk
Technical Levels
Financials
Peer Comparison
Speciality RetailPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| TRENT | Trent Limited | ₹2,755.30 | +1.64% |
| LENSKART | Lenskart Solutions Limited | ₹494.10 | -1.62% |
| MANYAVAR | Vedant Fashions Limited | ₹407.40 | +2.74% |
| ABFRL | Aditya Birla Fashion and Retail Limited | ₹59.90 | +2.85% |
| AVL | Aditya Vision Limited | ₹536.90 | +2.98% |
| ARVINDFASN | Arvind Fashions Limited | ₹450.20 | +0.95% |
| STYLEBAAZA | Baazar Style Retail Limited | ₹333.80 | +1.81% |
| GOCOLORS | Go Fashion (India) Limited | ₹358.65 | +4.55% |
| KALAMANDIR | Sai Silks (Kalamandir) Limited | ₹106.22 | +2.83% |
| V2RETAIL | V2 Retail Limited | ₹223.48 | +3.81% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for ABLBL
View AllVodafone Idea shares jump 4%; KM Birla says telco navigated through one of its toughest challenges in history
Vodafone Idea shares climbed after shareholders approved a Rs 4,730 crore investment from the Aditya Birla Group, signalling renewed promoter confidence. With funding support, easing AGR pressure and improved ratings, investor focus now shifts to execution, network expansion and the company’s long-term turnaround prospects.
AB Group reaffirms bet on Voda Idea with ₹4,730 Cr infusion
Vodafone Idea shareholders approved a ₹4,730-crore investment from the Aditya Birla Group via preferential allotment of warrants, increasing AB Group's stake to around 13%. Chairman Kumar Mangalam Birla stated the company's focus now shifts to execution across operations, customer service, and network expansion. This capital infusion will support capital expenditure and loan repayment, reinforcing Vi's financial health.
Market Trading Guide: Akums Drugs among 4 stock recommendations for Thursday
Domestic equities ended lower amid global uncertainty and caution ahead of key US inflation data. Despite market weakness, analysts remain bullish on Akums Drugs and Aditya Birla Sun Life AMC after strong technical breakouts, rising volumes and improving momentum indicators.